CDC20 increased expression has been observed in high-grade gliomas and linked to poor patient survival [76,85,86,87] while its knockdown reduced invasion, self-renewal, proliferation of GSCs and impaired tumor initiation [86,88,89]. The gene discussed is CDC20; the disease is central nervous system cancer.